Qian Liu

USPTO Granted Patents = 9 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 167(Granted Patents)

Location History:

Storrs, CT (US) (2006 - 2007)
Malden, MA (US) (2008 - 2015)

Company Filing History:

6 out of 757

University of Connecticut

Years Active: 2006-2015

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9108956 - Cyclic ether DGAT1 inhibitorscyclic ether DGAT1 inhibitors (2015-08-18),

2. 8993619 - Cyclic bridgehead ether DGAT1 inhibitors (2015-03-31),

3. 8877815 - Substituted carbamoylcycloalkyl acetic acid derivatives as NEP (2014-11-04),

4. 8084467 - Pyrazole derivatives as cannabinoid receptor antagonists (2011-12-27),

5. 7745440 - Pyrazole analogs acting on cannabinoid receptors (2010-06-29),

6. 7666867 - Heteroindanes: a new class of potent cannabimimetic ligands (2010-02-23),

7. 7393842 - Pyrazole analogs acting on cannabinoid receptors (2008-07-01),

8. 7276613 - Retro-anandamides, high affinity and stability cannabinoid receptor ligands (2007-10-02),

9. 7119108 - Pyrazole derivatives as cannabinoid receptor antagonists (2006-10-10),

Title: Innovator Spotlight: Qian Liu - Pioneering Inventor from Malden, MA

Introduction:

Qian Liu is a trailblazing inventor hailing from Malden, MA, with a remarkable portfolio of 9 patents to her name. Her innovative spirit and dedication to advancing the field of medicine have resulted in groundbreaking inventions that have the potential to revolutionize the treatment of metabolic disorders. Let's delve into the brilliant mind of Qian Liu and explore her journey in the world of inventions.

Latest Patents:

Qian Liu's latest patents showcase her expertise in developing compounds that target disorders mediated by acyl coA-diacylglycerol acyl transferase 1 (DGAT1). Specifically, her inventions revolve around cyclic ether DGAT1 inhibitors, compounds of formula (I) that exhibit utility in treating metabolic disorders. These patents not only introduce novel compounds but also encompass methods for treating such disorders, underscoring Qian Liu's innovative approach to medical solutions.

Career Highlights:

Throughout her illustrious career, Qian Liu has made significant contributions to the field of biotechnology through her work with esteemed institutions such as the University of Connecticut and Novartis AG. Her tenure at these prestigious organizations has provided her with a fertile ground for nurturing her inventive spirit and translating ideas into tangible patents that have the potential to impact countless lives.

Collaborations:

Qian Liu's collaborative efforts have been instrumental in realizing the full potential of her inventions. Working alongside accomplished peers like Alexandros Makriyannis and Rajesh Thotapally, she has been able to harness collective expertise and diverse perspectives to drive innovation forward. These collaborations have not only enriched her own work but have also fostered a culture of creativity and collaboration within the scientific community.

Conclusion:

In conclusion, Qian Liu stands as a shining example of a visionary inventor who is committed to pushing the boundaries of scientific discovery. Her passion for creating impactful solutions to complex medical problems is evident in her impressive patent portfolio and collaborative endeavors. As she continues her journey of innovation, we can only anticipate the groundbreaking inventions that Qian Liu will introduce to the world, further solidifying her legacy as a pioneering inventor in the realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.